AA Advanced Technology, Inc. Receives FDA Approval For MesoDerm(R)

AA Advanced Technology, Inc. has received Class III FDA approval for Mesoderm®, a no needle delivery system for mesotherapy drugs. Mesoderm® is the only Mesoporation® based technology that eliminates the need for hypodermic injections.


At the heart of MesoDerm® is a proprietary and patented technology called Mesos®. Developed by Microlab Biomedical Company in Italy, Mesos® allows a drug's penetration through the outermost skin layer. The process is based on the Mesoporation® principle developed by Dr. Aleksy Dobradin, MD and Dr. Renato Torre from Microlab Biomedical. Dr. Dobradin was the first doctor in the world to adopt MesoDerm® for Mesotherapy treatments. By eliminating injections, Mesotherapy procedures can be performed by unlicensed staff personnel under the supervision of a physician.


"We broke the Mesotherapy needle. The process is truly painless. There is no swelling, bruising, downtime or other complications. MesoDerm® means immediate results and ultimate comfort for patients." said Dr. Dobradin.


As a result of the FDA approval for Mesoderm®, AA Advanced Technology, Inc. is experiencing unprecedented interest from the medical community.


Says Dr. Dobradin "We pride ourselves on our total dedication to safety and the effectiveness of our product"


"We have a number of publications and studies proving our effectiveness." Said Kamil Kulczycki, AA Advanced Operations Manager. Many of them are published on American Journal of Mesotherapy web site.



MesoDerm®, Mesoporation® and Mesos® are a registered trademark of AA Advanced Technology, Inc. in the United States and/or other countries. The names of actual companies and products mentioned herein may be the trademarks of their respective owners.

AA Advanced Technology, Inc.